Skip to content

Author

Silvina Palmer

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

Real-world comparisons of venetoclax (VEN)-based versus hypomethylating agent (HMA) monotherapy in unfit, newly diagnosed AML remain limited by short follow-up, low genomic testing, and inadequate statistical power. We conducted the largest comparative analysis to date from the PETHEMA registry, including 2610 patients...

Gaspar Aspas Requena, Eliana Aguiar, Joana Brioso et al. · 0 citations
Open access Oct 2026

Impact of healthcare setting on survival in adults with acute lymphoblastic leukemia in Latin America: insights from a large multinational cohort

Survival of adults with ALL in Latin America has improved compared with historical reports, but substantial disparities persist between public and private settings, and upfront dasatinib was associated with improved OS, primarily through lower non-relapse mortality rather than reduced relapse incidence.

W. F. Silva, M. Espinoza, L. Ferrari et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.